Literature DB >> 31189963

Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.

Jill O Robinson1, Julia Wynn2, Barbara Biesecker3, Leslie G Biesecker4, Barbara Bernhardt5, Kyle B Brothers6, Wendy K Chung2,7, Kurt D Christensen8, Robert C Green8,9, Amy L McGuire1, M Ragan Hart10, Ida Griesemer11, Donald L Patrick12, Christine Rini13,14, David Veenstra15,16, Angel M Cronin17, Stacy W Gray18,19.   

Abstract

PURPOSE: As exome and genome sequencing (ES/GS) enters the clinic, there is an urgent need to understand the psychological effects of test result disclosure. Through a Clinical Sequencing Exploratory Research (CSER), phase 1 (CSER1) Consortium collaboration, we evaluated participants' psychological outcomes across multiple clinical settings.
METHODS: We conducted a random effects meta-analysis of state anxiety (Hospital Anxiety and Depression Scale [HADS]/Generalized Anxiety Disorder 7-item), depressive symptoms (HADS/Personal Health Questionnaire 9-item), and multidimensional impact (i.e., test-related distress, uncertainty and positive impact: modified Multidimensional Impact of Cancer Risk Assessment/Feelings About Genomic Testing Results scale).
RESULTS: Anxiety and depression did not increase significantly following test result disclosure. Meta-analyses examining mean differences from pre- to postdisclosure revealed an overall trend for a decrease in participants' anxiety. We observed low levels of test-related distress and perceptions of uncertainty in some populations (e.g., pediatric patients) and a wide range of positive responses.
CONCLUSION: Our findings across multiple clinical settings suggest no clinically significant psychological harms from the return of ES/GS results. Some populations may experience low levels of test-related distress or greater positive psychological effects. Future research should further investigate the reasons for test-related psychological response variation.

Entities:  

Keywords:  exome sequencing; genome sequencing; patient-reported outcomes; psychological effect; return of results

Mesh:

Year:  2019        PMID: 31189963      PMCID: PMC7260995          DOI: 10.1038/s41436-019-0565-3

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  36 in total

1.  The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.

Authors:  Meng Li; Caroline S Bennette; Laura M Amendola; M Ragan Hart; Patrick Heagerty; Bryan Comstock; Peter Tarczy-Hornoch; Stephanie M Fullerton; Dean A Regier; Wylie Burke; Susan B Trinidad; Gail P Jarvik; David L Veenstra; Donald L Patrick
Journal:  J Genet Couns       Date:  2018-12-14       Impact factor: 2.537

Review 2.  The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?

Authors:  Colleen M McBride; Laura M Koehly; Saskia C Sanderson; Kimberly A Kaphingst
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

3.  How could disclosing incidental information from whole-genome sequencing affect patient behavior?

Authors:  Kurt D Christensen; Robert C Green
Journal:  Per Med       Date:  2013-06       Impact factor: 2.512

4.  Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.

Authors:  Allyn McConkie Rosell; Loren D M Pena; Kelly Schoch; Rebecca Spillmann; Jennifer Sullivan; Stephen R Hooper; Yong-Hui Jiang; Nicolas Mathey-Andrews; David B Goldstein; Vandana Shashi
Journal:  J Genet Couns       Date:  2016-02-12       Impact factor: 2.537

5.  The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.

Authors:  Jason L Vassy; Kurt D Christensen; Erica F Schonman; Carrie L Blout; Jill O Robinson; Joel B Krier; Pamela M Diamond; Matthew Lebo; Kalotina Machini; Danielle R Azzariti; Dmitry Dukhovny; David W Bates; Calum A MacRae; Michael F Murray; Heidi L Rehm; Amy L McGuire; Robert C Green
Journal:  Ann Intern Med       Date:  2017-06-27       Impact factor: 25.391

6.  Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.

Authors:  Heidi S Lumish; Hallie Steinfeld; Carrie Koval; Donna Russo; Elana Levinson; Julia Wynn; James Duong; Wendy K Chung
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

7.  "I want to know what's in Pandora's Box": comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing.

Authors:  Anne Townsend; Shelin Adam; Patricia H Birch; Zoe Lohn; Francois Rousseau; Jan M Friedman
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

Review 8.  Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group.

Authors:  Stacy W Gray; Yolanda Martins; Lindsay Z Feuerman; Barbara A Bernhardt; Barbara B Biesecker; Kurt D Christensen; Steven Joffe; Christine Rini; David Veenstra; Amy L McGuire
Journal:  Genet Med       Date:  2014-03-13       Impact factor: 8.822

9.  Researchers' views on informed consent for return of secondary results in genomic research.

Authors:  Paul S Appelbaum; Abby Fyer; Robert L Klitzman; Josue Martinez; Erik Parens; Yuan Zhang; Wendy K Chung
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

Review 10.  Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.

Authors:  Jonathan S Berg; Laura M Amendola; Christine Eng; Eliezer Van Allen; Stacy W Gray; Nikhil Wagle; Heidi L Rehm; Elizabeth T DeChene; Matthew C Dulik; Fuki M Hisama; Wylie Burke; Nancy B Spinner; Levi Garraway; Robert C Green; Sharon Plon; James P Evans; Gail P Jarvik
Journal:  Genet Med       Date:  2013-10-24       Impact factor: 8.822

View more
  21 in total

Review 1.  Conceptualization of utility in translational clinical genomics research.

Authors:  Hadley Stevens Smith; Kyle B Brothers; Sara J Knight; Sara L Ackerman; Christine Rini; David L Veenstra; Amy L McGuire; Benjamin S Wilfond; Janet Malek
Journal:  Am J Hum Genet       Date:  2021-10-22       Impact factor: 11.025

Review 2.  Perceived Utility of Genomic Sequencing: Qualitative Analysis and Synthesis of a Conceptual Model to Inform Patient-Centered Instrument Development.

Authors:  Hadley Stevens Smith; Stephanie R Morain; Jill Oliver Robinson; Isabel Canfield; Janet Malek; Caryn Kseniya Rubanovich; Cinnamon S Bloss; Sara L Ackerman; Barbara Biesecker; Kyle B Brothers; Crispin N Goytia; Carol R Horowitz; Sara J Knight; Barbara Koenig; Stephanie A Kraft; Simon Outram; Christine Rini; Kelly J Shipman; Margaret Waltz; Benjamin Wilfond; Amy L McGuire
Journal:  Patient       Date:  2021-10-18       Impact factor: 3.481

Review 3.  Genetic Counseling and Genome Sequencing in Pediatric Rare Disease.

Authors:  Alison M Elliott
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

4.  Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Kandamurugu Manickam; Monica R McClain; Laurie A Demmer; Sawona Biswas; Hutton M Kearney; Jennifer Malinowski; Lauren J Massingham; Danny Miller; Timothy W Yu; Fuki M Hisama
Journal:  Genet Med       Date:  2021-07-01       Impact factor: 8.822

5.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).

Authors:  David T Miller; Kristy Lee; Adam S Gordon; Laura M Amendola; Kathy Adelman; Sherri J Bale; Wendy K Chung; Michael H Gollob; Steven M Harrison; Gail E Herman; Ray E Hershberger; Teri E Klein; Kent McKelvey; C Sue Richards; Christopher N Vlangos; Douglas R Stewart; Michael S Watson; Christa Lese Martin
Journal:  Genet Med       Date:  2021-05-20       Impact factor: 8.822

Review 6.  Genetic Counseling, Personalized Medicine, and Precision Health.

Authors:  Erica Ramos
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 5.159

Review 7.  Cancer Genetic Counseling-Current Practice and Future Challenges.

Authors:  Jaclyn Schienda; Jill Stopfer
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

8.  Hope versus reality: Parent expectations of genomic testing.

Authors:  Katherine E Donohue; Siobhan M Dolan; Dana Watnick; Katie M Gallagher; Jacqueline A Odgis; Sabrina A Suckiel; Nehama Teitelman; Bruce D Gelb; Eimear E Kenny; Melissa P Wasserstein; Carol R Horowitz; Laurie J Bauman
Journal:  Patient Educ Couns       Date:  2021-01-29

9.  Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis.

Authors:  Chloe Mighton; Salma Shickh; Elizabeth Uleryk; Petros Pechlivanoglou; Yvonne Bombard
Journal:  Genet Med       Date:  2020-09-14       Impact factor: 8.822

10.  Effects of participation in a U.S. trial of newborn genomic sequencing on parents at risk for depression.

Authors:  Talia S Schwartz; Kurt D Christensen; Melissa K Uveges; Susan E Waisbren; Amy L McGuire; Stacey Pereira; Jill O Robinson; Alan H Beggs; Robert C Green; Gloria A Bachmann; Arnold B Rabson; Ingrid A Holm
Journal:  J Genet Couns       Date:  2021-07-26       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.